Physio-Control Release: Large Randomized Trial: LUCAS Chest Compression System is Effective and Reliable in Pre-Hospital Cardiac Arrest

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

REDMOND, Wash.--(BUSINESS WIRE)--Physio-Control, Inc., the world’s leading provider of professional emergency response solutions, announced today that the main results of the large randomized LINC study which compared the effectiveness of the LUCAS® mechanical chest compression system to high-quality manual chest compressions were presented at the European Society of Cardiology Congress in Amsterdam, the Netherlands. The LINC study showed similar short-term survival rates for LUCAS (23.6%) and manual (23.7%) chest compressions. At 6 months, 8.5% of the patients treated with LUCAS were alive with good neurological outcomes compared to 7.6% in the manual group.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC